PMDA drug package insert
プリンスアイ
PMDA OTC drug · 日新薬品工業（株） · package insert Apr 10, 2026
Key facts
| Brand names | プリンスアイ |
|---|---|
| Companies | 製造販売元／佐賀製薬（株）,販売元／日新薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | 液剤 |
| OTC effect category | 一般点眼薬 |
| Package insert date | Apr 10, 2026 |
| PMDA document key | 300041_J2601000064 |
| PMDA company code | 300041 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: